Search - tctmd.com

Displaying 1 - 18 of 18

Sort: Relevancy | Date

News Daily News

Top General Cardiology and Prevention News of 2024

Caitlin E. Cox

December 30, 2024

News Daily News

Female-Specific Factors Don’t Enhance Common Risk Calculators

Caitlin E. Cox

December 10, 2024

News Conference News AHA 2024

Two Lp(a)-Lowering Therapies Clear Bar in KRAKEN and ALPACAR-360

Michael O'Riordan

November 18, 2024

News Conference News AHA 2024

One Hundred Years and Beyond: What's Going to Be Hot at AHA 2024

Shelley Wood

November 14, 2024

News Conference News TCT 2024

Safety Retained When Fellows Lead Complex PCI Procedures

Yael L. Maxwell

October 27, 2024

News Daily News

Low CV Risk With ‘Living’ Cancer Therapies, Meta-analysis Shows

L.A. McKeown

October 09, 2024

News Conference News ESC 2024

Getting to Cholesterol Goal Early After MI Lowers Risk of Recurrent Events

Michael O'Riordan

September 01, 2024

News Conference News ESC 2024

Polypills Show Promise in Diverse Hypertensive Patient Groups

L.A. McKeown

August 31, 2024

News Daily News

Marked LDL Lowering With Obicetrapib in HeFH: BROOKLYN

Michael O'Riordan

July 29, 2024

News Daily News

Need a Cardiologist? Nearly Half of All US Counties Have None

L.A. McKeown

July 09, 2024

News Conference News ACC 2024

NOW PUBLISHED - LIBerate-HR: Lerodalcibep Lowers LDL More Sharply Than Placebo Over 1 Year

Yael L. Maxwell

July 03, 2024

News Daily News

As Trends Reverse in CVD, AHA Warns of Soaring Costs and Illness

L.A. McKeown

June 05, 2024

News Daily News

Lp(a) Linked to Higher ASCVD Risks in Diverse Patient Groups

Michael O'Riordan

April 17, 2024

News Conference News ACC 2024

Telemedicine Strategy After MI Scores a Win in TELE-ACS

Caitlin E. Cox

April 12, 2024

News Conference News ACC 2024

Compared With Usual Care, Incorporating Inclisiran Early Cuts LDL

Yael L. Maxwell

April 09, 2024

News Opinion CV Team Dispatch

February 2024 Dispatch for the CV Team

L.A. McKeown

February 01, 2024

News Daily News

Universal Risk Tool Works Well in Both Primary and Secondary Prevention

Michael O'Riordan

February 01, 2024

Presentation Complex Coronary Cases 2023

Eliminating Coronary Artery Disease: Targeting Hypercholesterolemia and Inflammation

Presenter: Marc S. Sabatine

June 15, 2023

Advertisement

Top General Cardiology and Prevention News of 2024

Female-Specific Factors Don’t Enhance Common Risk Calculators

Two Lp(a)-Lowering Therapies Clear Bar in KRAKEN and ALPACAR-360

One Hundred Years and Beyond: What's Going to Be Hot at AHA 2024

Safety Retained When Fellows Lead Complex PCI Procedures

Low CV Risk With ‘Living’ Cancer Therapies, Meta-analysis Shows

Getting to Cholesterol Goal Early After MI Lowers Risk of Recurrent Events

Polypills Show Promise in Diverse Hypertensive Patient Groups

Marked LDL Lowering With Obicetrapib in HeFH: BROOKLYN

Need a Cardiologist? Nearly Half of All US Counties Have None

NOW PUBLISHED - LIBerate-HR: Lerodalcibep Lowers LDL More Sharply Than Placebo Over 1 Year

As Trends Reverse in CVD, AHA Warns of Soaring Costs and Illness

Lp(a) Linked to Higher ASCVD Risks in Diverse Patient Groups

Telemedicine Strategy After MI Scores a Win in TELE-ACS

Compared With Usual Care, Incorporating Inclisiran Early Cuts LDL

February 2024 Dispatch for the CV Team

Universal Risk Tool Works Well in Both Primary and Secondary Prevention

Eliminating Coronary Artery Disease: Targeting Hypercholesterolemia and Inflammation

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content